Sometimes even the
experts need experts.
experts need experts.
We match oncologists like you with peer experts so you can make better-informed treatment decisions about your most complex cases.
.png)
Would you administer CAR-T in a DLBCL patient with central nervous system involvement of their malignancy?
Yes, I have given CAR-T to patients like that. It might make the benefit to risk ratio a bit less favorable, but it’s still a viable option. Let’s discuss further.
.png)
“The oncology field is changing so fast– new drugs, new therapies– it’s overwhelming. I don’t have enough time to distill it all.”
“I value talking to peers who have made it their life’s work to specialize in a specific area. It’s not always easy to find or access them when I have questions.”
“I strictly follow the NCCN and ASCO guidelines, yet lymphoma and myeloma still require a lot of judgment. There is a wide range for discretion in therapeutic decision-making and drug selection.”
“Every 2-4 weeks, new research comes out that causes me to change something in my treatment plans.”
The more our network grows, the better we can help other oncologists develop well-informed treatment plans.
BECOME AN EXPERT.png)
.png)
Join Primum and connect with a vast network of oncologists, so you can set knowledge free.
JOIN OUR COMMUNITY
